ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,544 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenMabylon AG
Mabylon AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

The core activity of Mabylon AG is research and development in the field of biotechnology.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Mabylon AG

✓ Offered4
Antibody-based drug discovery
Discovery and engineering of novel antibody therapeutics using human B-cell screening technologies, high-throughput expression, and antibody engineering for validated targets.
Therapeutics for allergies
Antibody-based therapeutics for food and pollen allergies, in particular for peanut allergy, birch pollen allergy, and grass pollen allergy.
Therapeutics for inflammation and neurodegeneration
Development of human antibodies for inflammatory and neurological diseases, including ALS, Alzheimer’s disease, and inflammatory bowel diseases.
Partnering for research and development collaborations
Collaboration opportunities with academic and commercial partners to further develop programs in neurology, severe food allergies, seasonal allergies, and immunology.
Trust & reputation

ranQ Trust Score of Mabylon AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 100% · As of October 2026

Mabylon AG scores 61.5 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.69.624%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.35.310%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.70.08%
Mabylon AG scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Mabylon AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Mabylon AG scores 63.8 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.94.34%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.33.34%
Qualifications+0.00

Mabylon AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». The rating draws, among other things, on 4.7 out of 5 stars from 3 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.7
of 5

Aggregated from 3 reviews across all connected sources

Sources
GGoogle4.73
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

April 30, 2026Media
Three Swiss deep tech startups secure Eureka funding
startupticker.ch
April 30, 2026Media
Mabylon sichert sich Eurostar-Zuschuss von 1,46 Millionen Euro
punkt4.info
December 11, 2025Media
Mabylon beginnt Phase-I-Studie zur Prophylaxe bei Erdnussallergie
punkt4.info
August 12, 2025Media
Mabylon raises CHF 30 million to fight allergies with human-derived antibodies
startupticker.ch

Knowledge

No knowledge articles yet

Once Mabylon AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Mabylon AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Mabylon AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Mabylon AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 14
8952 Schlieren
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-353.226.343
Founded
2011 · 15 years
Last commercial register change
July 3, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    NS
    Neurimmune Subone AG
    Schlieren
    NA
    Neurimmune AG
    Schlieren
    AA
    Athebio AG
    Schlieren
    IB
    InterAx Biotech AG
    Schlieren
    MP
    Molecular Partners AG
    Schlieren
    AT
    Axanton Technology GmbH
    Schlieren
    PA
    Philochem AG
    Otelfingen
    FP
    Fahrländer Partner AG
    Zurich